MHRAsafety guidance54% confidence
Transparency data: Medicines and Healthcare products Regulatory Agency Privacy Notice
Source: MHRA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Accord Biopharma.
Regulatory Analysis
This privacy notice describes how we collect and use your personal information, in accordance with the Data Protection Act and the General Data Protection Regulation.
Supporting Context
- Therapeutic area
- Immunology · TNF Inhibitor
- Sub-indication
- General
Related signal: FDA Accepts BLA for IMMGOLIS (GOLIMUMAB-SLDI) by Accord Biopharma